TrialNCT07637162Phase 3Enrolling by invitation
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Study sponsor: Axsome Therapeutics, Inc. · AXSM
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2028-05Estimated
Enrollment · participants300Estimated
Source updated2026-09-04Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.